Gpnmb/Osteoactivin as a drug target and biomarker in cardiac diseases
    1.
    发明公开
    Gpnmb/Osteoactivin as a drug target and biomarker in cardiac diseases 审中-公开
    GPNMB / Osteoactivin als Arzneimitteltarget和Biomarker bei Herzerkrankungen

    公开(公告)号:EP2460890A1

    公开(公告)日:2012-06-06

    申请号:EP10193362.0

    申请日:2010-12-01

    IPC分类号: C12Q1/68

    摘要: The present invention relates to the gene Gpnmb and its use as a genetic marker in the incidence of cardiovascular conditions and cardiac diseases, such as complications derived from myocardial infarction. Gpnmb provides a valuable tool both for diagnostic as well as therapeutic approaches, in order to treat or prevent cardiovascular conditions and cardiac diseases, in particular complications derived from myocardial infarction.

    摘要翻译: 本发明涉及基因Gpnmb及其在心血管疾病和心脏病发病中的遗传标记物的用途,例如由心肌梗死引起的并发症。 Gpnmb为诊断和治疗方法提供了宝贵的工具,以治疗或预防心血管疾病和心脏疾病,特别是由心肌梗死引起的并发症。